ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 99 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,906 | -82.7% | 9,165 | -81.9% | 0.00% | – |
Q1 2022 | $63,000 | -37.6% | 50,643 | -19.7% | 0.00% | – |
Q4 2021 | $101,000 | -51.0% | 63,052 | 0.0% | 0.00% | – |
Q3 2021 | $206,000 | -79.8% | 63,052 | -60.9% | 0.00% | -100.0% |
Q2 2021 | $1,019,000 | – | 161,269 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 524,805 | $572,000 | 0.39% |
Laurion Capital Management LP | 2,225,800 | $2,426,000 | 0.04% |
Ergoteles LLC | 514,600 | $561,000 | 0.02% |
Pinz Capital Management, LP | 17,900 | $20,000 | 0.01% |
Alpine Global Management, LLC | 37,089 | $40,000 | 0.01% |
Game Plan Financial Advisors, LLC | 10,000 | $11,000 | 0.01% |
Spire Wealth Management | 100,300 | $109,000 | 0.00% |
Renaissance Technologies | 1,989,995 | $2,169,000 | 0.00% |
D. E. Shaw & Co., Inc. | 2,279,636 | $2,485,000 | 0.00% |
Y-Intercept (Hong Kong) Ltd | 16,912 | $18,000 | 0.00% |